pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Prolong Pharmaceuticals, LLC, is developing products to treat several diseases and their debilitating comorbidities associated with reduced quality of life, increased medical cost and significant mortality.
LOCATION
South Plainfield, NJ, USA
THERAPEUTIC AREAS
Hematology
Rare Diseases
WEBSITE
https://www.prolongpharma.com/
CAREER WEBSITE
https://www.prolongpharma.com/the-career-center/
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
Dec 13, 2017
Prolong Pharmaceuticals Announces Completion of Enrollment in Phase II Study of SANGUINATE in the Treatment of Sickle Cell Disease Patients with Vaso-Occlusive Crisis in an Ambulatory Setting
Nov 8, 2017
Prolong Pharmaceuticals to Present New Research on SANGUINATE, an Investigational Treatment Under Evaluation for Vaso-Occlusive Crisis (VOC) in Patients with Sickle Cell Disease, at ASH Annual Meeting
Apr 14, 2015
Prolong Pharmaceuticals Presents Data on Unique "Un-Sickling" In Vitro Activity Observed in Sickle Cell Investigational Drug SANGUINATE
Apr 8, 2015
Prolong Pharmaceuticals' Flagship Product SANGUINATE™ Granted Orphan Drug Designation by the FDA
Dec 18, 2013
Prolong Pharmaceuticals Adds Industry Veteran Ronald Jubin To Executive Management Team
For More Press Releases